P. Abram
Impact in
-
- Breast Cancer Treatment Studies
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Risks and Factors
Papers in
-
- Breast Cancer Treatment Studies 7
- Oncology 6
- HER2/EGFR in Cancer Research 4
- Pancreatic and Hepatic Oncology Research 1
- Cancer Treatment and Pharmacology 1
- Colorectal Cancer Treatments and Studies 1
- Co-authors
- Anthony Howell (2 shared papers)Toru Watanabe (1 shared paper)J.F.R. Robertson (1 shared paper)Emilio Bajetta (1 shared paper)C. Kent Osborne (1 shared paper)Isaiah W. Dimery (1 shared paper)Alan Webster (1 shared paper)Charles Morris (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Cancer Treatment Reviews (2 papers)The Breast (1 paper)Breast Cancer Research and Treatment (1 paper)Cancer Research (1 paper)
- Partner nations
- United KingdomGermanyAustria
In The Last Decade
P. Abram
10 papers receiving 436 citations
Peers
Comparison fields: 5 of 52
- Cancer Research 129
- Oncology 229
- Genetics 244
- Pulmonary and Respiratory Medicine 153
- Toxicology 7
Countries citing papers authored by P. Abram
This map shows the geographic impact of P. Abram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Abram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Abram more than expected).
Fields of papers citing papers by P. Abram
This network shows the impact of papers produced by P. Abram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Abram. The network helps show where P. Abram may publish in the future.
Co-authors
The 25 scholars most cited alongside P. Abram, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 310 | |
| 2 | 2008 | 65 | |
| 3 | 2005 | 63 | |
| 4 | 2005 | 20 | |
| 5 | 2009 | 6 | |
| 6 | Elevated serum and mononuclear leukocyte thymidine kinase activities in patients with cancer. | 1987 | 4 |
| 7 | 2010 | 3 | |
| 8 | 2010 | 2 | |
| 9 | 2009 | 1 | |
| 10 | 2005 | 1 |
About P. Abram
P. Abram is a scholar working on Cancer Research, Oncology, Genetics, Pulmonary and Respiratory Medicine and Epidemiology, having authored 10 papers that have together received 475 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (7 papers), Estrogen and related hormone effects (6 papers), HER2/EGFR in Cancer Research (4 papers), Advanced Breast Cancer Therapies (4 papers), Pancreatic and Hepatic Oncology Research (1 paper), Neuroendocrine Tumor Research Advances (1 paper), Cancer Treatment and Pharmacology (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Cancer Research (129 citations), Oncology (229 citations), Genetics (244 citations), Pulmonary and Respiratory Medicine (153 citations) and Toxicology (7 citations). P. Abram has collaborated with scholars based in United Kingdom, Germany and Austria. Frequent co-authors include Anthony Howell, Toru Watanabe, J.F.R. Robertson, Emilio Bajetta, C. Kent Osborne, Isaiah W. Dimery, Alan Webster, Charles Morris, Richard Elledge and Mikhail Lichinitser. Their work appears in journals such as Journal of Clinical Oncology, Cancer Treatment Reviews, The Breast, Breast Cancer Research and Treatment and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.